Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
McGill University
$27,000.00
Predictive power of IgA responses for sex differences in muscle-invasive bladder cancer
FY 2025-26
Summary
Muscle-invasive bladder cancer (MIBC) is a serious disease with poor survival rates in Canada. Despite men being three times more likely to develop this cancer, women often present with more advanced disease and experience worse response rates to bladder-preserving treatment. This suggests that important biological differences between men and women may be influencing disease outcomes. Our research focuses on IgA, an antibody that plays an important role in the body's immune system, including the bladder. IgA comes in two forms and is known to behave differently in men and women in other organs, partly because it is influenced by hormones such as estrogen and testosterone. Early results from our work show that IgA may also act differently in bladder cancer. In men, high IgA levels within tumours have been linked to worse outcomes, but our data suggests that in women, certain types of IgA may be linked to better survival. We believe that IgA may help protect women with bladder cancer but may not have the same effect in men, and that these differences are partly controlled by hormonal signals. To investigate this, we will examine where IgA appears within bladder tumours and how strongly hormone receptors are active in men, perimenopausal women, and postmenopausal women. We will also measure IgA in urine, which is a simple, non-invasive test. We will combine these results with clinical information to build a machine learning tool that predicts who is likely to benefit from bladder-preserving chemoradiation and who may face a higher risk of the cancer returning. This research aims to uncover sex- and hormone-specific immune patterns, identify urine IgA as a promising new biomarker, and create a predictive model to help personalize treatment for both men and women.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
572856
Name
Chevalier Rachel
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Predictive power of IgA responses for sex differences in muscle-invasive bladder cancer
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Enzyme-Linked Immunosorbent Assay; Hormonal Regulation; Immunoglobulin A; Immunohistochemical Staining; Machine Learning; Mucosal Immunology; Muscle-Invasive Bladder Cancer; Precision Medicine; Predictive Model; Sex Differences
Abstract
Muscle-invasive bladder cancer (MIBC) is a serious disease with poor survival rates in Canada. Despite men being three times more likely to develop this cancer, women often present with more advanced disease and experience worse response rates to bladder-preserving treatment. This suggests that important biological differences between men and women may be influencing disease outcomes. Our research focuses on IgA, an antibody that plays an important role in the body's immune system, including the bladder. IgA comes in two forms and is known to behave differently in men and women in other organs, partly because it is influenced by hormones such as estrogen and testosterone. Early results from our work show that IgA may also act differently in bladder cancer. In men, high IgA levels within tumours have been linked to worse outcomes, but our data suggests that in women, certain types of IgA may be linked to better survival. We believe that IgA may help protect women with bladder cancer but may not have the same effect in men, and that these differences are partly controlled by hormonal signals. To investigate this, we will examine where IgA appears within bladder tumours and how strongly hormone receptors are active in men, perimenopausal women, and postmenopausal women. We will also measure IgA in urine, which is a simple, non-invasive test. We will combine these results with clinical information to build a machine learning tool that predicts who is likely to benefit from bladder-preserving chemoradiation and who may face a higher risk of the cancer returning. This research aims to uncover sex- and hormone-specific immune patterns, identify urine IgA as a promising new biomarker, and create a predictive model to help personalize treatment for both men and women.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chevalier, Rachel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~